| J9271 | Injection, pembrolizumab, 1 mg | 9,200 | $40 | $395.6K |
| J0897 | Injection, denosumab, 1 mg | 8,460 | $20 | $152.3K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 3,600 | $20 | $57.6K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 28,300 | $1 | $56.6K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 660 | $70 | $45.2K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 34,500 | $1 | $34.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 320 | $100 | $32.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 210 | $100 | $20.9K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 170 | $100 | $16.5K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 100 | $150 | $13.9K |